Relmada Therapeutics (RLMD) Depreciation and Depletion (2014 - 2021)
Relmada Therapeutics (RLMD) reported Depreciation and Depletion of $452.0 for Q2 2021, down 56.07% year-over-year from $1029.0 in Q2 2020, and down 43.92% quarter-over-quarter from $806.0 in Q1 2021.
Relmada Therapeutics (RLMD) Depreciation and Depletion (2014 - 2021) Analysis & Trends
Relmada Therapeutics (RLMD) has 8 years of Depreciation and Depletion data on file, last reported at $452.0 in Q2 2021.
- Depreciation and Depletion for Q2 2021 came in at $452.0, down 56.07% year-over-year; the trailing twelve-month figure through Dec 2021 was $1258.0 (down 66.47% YoY), and the FY2021 annual result was $1258.0, down 66.47% from the prior year.
- Depreciation and Depletion retreated to $452.0 in Q2 2021 per RLMD's latest filing, from $806.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $23268.0 in Q1 2017 and troughed at -$556.0 in Q4 2018.
- A 5-year average of $3271.9 and a median of $1029.0 in 2020 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2018 and 2019: Depreciation and Depletion slumped 195.53% in 2018, then soared 495.68% in 2019.
- A 5-year view of Depreciation and Depletion shows it stood at $582.0 in 2017, then sank by 195.53% to -$556.0 in 2018, then soared by 495.68% to $2200.0 in 2019, then plunged by 62.59% to $823.0 in 2020, then tumbled by 45.08% to $452.0 in 2021.
- Business Quant data shows RLMD's Depreciation and Depletion at $452.0 in Q2 2021, $806.0 in Q1 2021, and $823.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Relmada Therapeutics | 581.07 Mn | 581.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 452.00 |
| Jun 30, 2021 | 452.00 |
| Mar 31, 2021 | 806.00 |
| Mar 31, 2021 | 806.00 |
| Dec 31, 2020 | 823.00 |
| Dec 31, 2020 | 823.00 |
| Sep 30, 2020 | 854.00 |
| Sep 30, 2020 | 854.00 |
| Jun 30, 2020 | 1,029.00 |
| Jun 30, 2020 | 1,029.00 |
| Mar 31, 2020 | 1,046.00 |
| Mar 31, 2020 | 1,046.00 |
| Dec 31, 2019 | 2,200.00 |
| Dec 31, 2019 | 2,200.00 |
| Sep 30, 2019 | 1,100.00 |
| Sep 30, 2019 | 1,100.00 |
| Jun 30, 2019 | 2,163.00 |
| Jun 30, 2019 | 2,163.00 |
| Mar 31, 2019 | 1,075.00 |
| Mar 31, 2019 | 1,075.00 |